For the Inventor, By the Inventor

Enter assignee name

Research Triangle Park, NC, United States of America

Glaxo Wellcome Inc.

USPTO Granted Patents = 281

CIPO Patents = 2

Trademarks = 11

Forward Citations = 5,438

Loading Chart...

Loading Chart...

473 inventors (with patents filed for the assignee):

Susan Mary Daluge (15 out of 46 patents)

George Walter Koszalka (9 out of 18 patents)

Timothy Mark Willson (9 out of 20 patents)

4. Thomas A Krenitsky (8 out of 40 patents)

5. Malcolm Stuart Nobbs (8 out of 12 patents)

6. Scott Howard Dickerson (7 out of 18 patents)

7. David Lee Musso (7 out of 15 patents)

8. Elizabeth Ellen Sugg (7 out of 8 patents)

9. Harry Finch (7 out of 47 patents)

10. Stephen V Frye (7 out of 15 patents)

11. Thomas Spector (6 out of 14 patents)

12. James L Kelley (6 out of 19 patents)

13. Barry George Shearer (6 out of 11 patents)

14. Haim Kedar (6 out of 14 patents)

15. Saad George Rahim (6 out of 14 patents)

Core Competencies:

Antiviral Properties

Antibodies to CD23

Combinatorial Library Evaluation

Protein Kinase Inhibitors

Vaccine Compositions

Therapeutic Agents

High Throughput Screening

Recombinant Viruses

CNS Disorder Treatment

Inhalation Devices

Medicaments for IBS

Nano-Grid Micro Reactor

281 patents: Sort by Forward Citations

1. 7166287 - Viral agent (2007-01-23),

2. 7119202 - Substituted-1,3-oxathiolanes and substituted-1,3-dioxolanes with antiviral properties (2006-10-10),

3. 7008623 - Antibodies to CD23, derivatives thereof, and their therapeutic uses (2006-03-07),

4. 6913930 - Analytical method and apparatus therefor involving continuous titration (2005-07-05),

5. 6875449 - Crystal structure (2005-04-05),

6. 6767996 - Altered antibodies and their preparation (2004-07-27),

7. 6706244 - Apparatus and methods for evaluating the quality of a combinatorial library of compounds (2004-03-16),

8. 6645960 - Antifungal sordaricin derivatives (2003-11-11),

9. 6509447 - G protein chimeras and methods of screening compounds (2003-01-21),

10. 6410528 - Morpholino ethers (2002-06-25),

11. 6387919 - Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors (2002-05-14),

12. 6383498 - Compositions for vaccines (2002-05-07),

13. 6355646 - Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9H-purin-8-yl)phenyl derivatives, their preparation and their use in treatment of inflammatory conditions and immune disorders (2002-03-12),

14. 6350747 - 3-(anilinomethylene) oxindoles (2002-02-26),

15. 6345740 - Valve for aerosol container (2002-02-12),

Glaxo Wellcome Inc. is a leading global healthcare company that focuses on researching, developing, and manufacturing innovative pharmaceutical products. With a diverse portfolio of prescription medicines, vaccines, and consumer healthcare products, Glaxo Wellcome is dedicated to improving the quality of human life. The company strives to provide effective solutions to global health challenges and make a positive impact on communities worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

281 Patents

#3 in Research Triangle Park, NC

#43 in North Carolina

#1,490 in US

#3,059 in the World

Research Triangle Park, NC, United States of America

Glaxo Wellcome Inc.

Forward Citations = 5,438

473 inventors:

Susan Mary Daluge (15 out of 46 patents)

George Walter Koszalka (9 out of 18 patents)

Timothy Mark Willson (9 out of 20 patents)

4. Thomas A Krenitsky (8 out of 40 patents)

5. Malcolm Stuart Nobbs (8 out of 12 patents)

Please report any incorrect information to support@idiyas.com

Loading…